IE 11 is a very old Browser and it`s not supported on this site

Performance / Multi-year comparison

Indexed performance since launch (in CHF)

BB Biotech AG (SIX)-CHF

Platzhaltergrafik


Rolling performance

 

 

SHARE

 

NAV

 

NBI TR

31.03.2020 – 31.03.2021

 

63.3%

 

67.9%

 

36.7%

31.03.2019 – 31.03.2020

 

(19.5%)

 

(26.6%)

 

(5.8%)

31.03.2018 – 31.03.2019

 

8.3%

 

11.7%

 

9.5%

31.03.2017 – 31.03.2018

 

25.6%

 

10.9%

 

5.0%

31.03.2016 – 31.03.2017

 

29.2%

 

30.0%

 

17.9%

Annual performance

 

 

SHARE

 

NAV

 

NBI TR

2020

 

19.3%

 

24.3%

 

15.8%

2019

 

18.5%

 

23.4%

 

23.0%

2018

 

(5.2%)

 

(14.5%)

 

(8.0%)

2017

 

22.9%

 

23.4%

 

16.4%

2016

 

0.2%

 

(19.3%)

 

(20.0%)

Cumulated performance

31.03.2021

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

15.4%

 

5.5%

 

5.8%

1 year

 

63.3%

 

67.9%

 

36.7%

3 years

 

42.5%

 

37.7%

 

41.0%

5 years

 

128.7%

 

97.2%

 

74.7%

since inception 1)

 

3 304%

 

2 732%

 

1 438%

1 09.11.1993

Annualized performance

31.03.2021

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

63.3%

 

67.9%

 

36.7%

3 years

 

12.5%

 

11.2%

 

12.1%

5 years

 

18.0%

 

14.5%

 

11.8%

since inception 1)

 

13.7%

 

13.0%

 

10.5%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR

Platzhaltergrafik


Rolling performance

 

 

SHARE

 

NAV

 

NBI TR

31.03.2020 – 31.03.2021

 

58.5%

 

60.7%

 

30.8%

31.03.2019 – 31.03.2020

 

(16.2%)

 

(22.6%)

 

(0.6%)

31.03.2018 – 31.03.2019

 

14.5%

 

17.8%

 

15.3%

31.03.2017 – 31.03.2018

 

14.5%

 

1.0%

 

(4.4%)

31.03.2016 – 31.03.2017

 

31.9%

 

33.1%

 

20.3%

Annual performance

 

 

SHARE

 

NAV

 

NBI TR

2020

 

18.1%

 

24.8%

 

16.1%

2019

 

23.4%

 

28.1%

 

27.6%

2018

 

(2.2%)

 

(11.1%)

 

(4.3%)

2017

 

12.9%

 

12.5%

 

6.7%

2016

 

1.7%

 

(17.8%)

 

(19.0%)

Cumulated performance

31.03.2021

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

14.3%

 

2.9%

 

3.5%

1 year

 

58.5%

 

60.7%

 

30.8%

3 years

 

52.1%

 

46.4%

 

49.9%

5 years

 

127.0%

 

95.0%

 

72.3%

since inception 1)

 

2 579%

 

2 120%

 

1 361%

1 10.12.1997

Annualized performance

31.03.2021

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

58.5%

 

60.7%

 

30.8%

3 years

 

15.0%

 

13.5%

 

14.4%

5 years

 

17.8%

 

14.3%

 

11.5%

since inception 1)

 

15.1%

 

14.2%

 

12.2%

1 10.12.1997

BB BIOTECH AG (MILAN)-EUR

Platzhaltergrafik


Rolling performance

 

 

SHARE

 

NAV

 

NBI TR

31.03.2020 – 31.03.2021

 

57.6%

 

60.7%

 

30.8%

31.03.2019 – 31.03.2020

 

(14.7%)

 

(22.6%)

 

(0.6%)

31.03.2018 – 31.03.2019

 

13.0%

 

17.8%

 

15.3%

31.03.2017 – 31.03.2018

 

12.8%

 

1.0%

 

(4.4%)

31.03.2016 – 31.03.2017

 

32.4%

 

33.1%

 

20.3%

Annual performance

 

 

SHARE

 

NAV

 

NBI TR

2020

 

19.7%

 

24.8%

 

16.1%

2019

 

22.6%

 

28.1%

 

27.6%

2018

 

(1.3%)

 

(11.1%)

 

(4.3%)

2017

 

12.2%

 

12.5%

 

6.7%

2016

 

1.2%

 

(17.8%)

 

(19.0%)

Cumulated performance

31.03.2021

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

13.2%

 

2.9%

 

3.5%

1 year

 

57.6%

 

60.7%

 

30.8%

3 years

 

51.8%

 

46.4%

 

49.9%

5 years

 

126.7%

 

95.0%

 

72.3%

since inception 1)

 

517%

 

412%

 

186%

1 19.10.2000

Annualized performance

31.03.2021

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

57.6%

 

60.7%

 

30.8%

3 years

 

14.9%

 

13.5%

 

14.4%

5 years

 

17.8%

 

14.3%

 

11.5%

since inception 1)

 

9.3%

 

8.3%

 

5.3%

1 19.10.2000

Multi-year comparison

 

 

31.03.2021

 

2020

 

2019

 

2018

 

2017

 

 

Market capitalization at the end of the period (in CHF mn)

 

4 553.9

 

4 107.9

 

3 670.3

 

3 235.4

 

3 576.1

 

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

 

3 918.5

 

3 887.5

 

3 393.0

 

2 884.5

 

3 538.7

 

highchart-toggle

Number of shares (in mn)

 

55.4

 

55.4

 

55.4

 

55.4

 

55.4

 

highchart-toggle

Trading volume (in CHF mn)

 

801.9

 

2 315.6

 

2 004.2

 

2 610.7

 

2 864.7

 

highchart-toggle

Profit/(loss) (in CHF mn)

 

220.9

 

691.2

 

677.4

 

(471.3)

 

687.5

 

highchart-toggle

Closing price at the end of the period in CHF

 

82.20

 

74.15

 

66.25

 

58.40

 

64.55

 

highchart-toggle

Closing price (G) at the end of the period in EUR

 

74.70

 

68.00

 

61.40

 

52.00

 

55.68

 

highchart-toggle

Closing price (I) at the end of the period in EUR

 

74.50

 

68.50

 

61.00

 

52.00

 

55.20

 

highchart-toggle

Stock performance (incl. distributions) 1)

 

15.4%

 

19.3%

 

18.5%

 

(5.2%)

 

22.9%

 

highchart-toggle

High/low share price in CHF

 

92.20/73.40

 

74.70/45.44

 

73.20/59.35

 

74.10/56.10

 

67.80/52.10

 

highchart-toggle

High/low share price in EUR

 

86.20/67.80

 

69.00/43.04

 

64.70/52.10

 

64.80/48.60

 

59.10/48.42

 

highchart-toggle

Premium/(discount) (annual average)

 

10.7%

 

9.2%

 

11.8%

 

9.7%

 

(2.5%)

 

highchart-toggle

Dividend in CHF

 

N.A.

 

3.60

 

3.40

 

3.05

 

3.30

 

highchart-toggle

Degree of investment (quarterly figures)

 

109.2%

 

106.8%

 

109.1%

 

108.4%

 

103.1%

 

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

 

1.23%

 

1.25%

 

1.26%

 

1.25%

 

1.27%

 

highchart-toggle

1 All figures in CHF %, total return-methodology

2 Based on market capitalization

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer